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054 The Journal of Thoracic and Cardbjective: Our approach to the extracardiac conduit Fontan operation has evolved
ver time from full-pump, to partial-pump, to completely off-pump. This study is
esigned to report our overall experience with the extracardiac conduit Fontan
peration and to evaluate the evolution in bypass technique on postoperative
utcomes.
ethods: From September 1992 to April 2005, 285 patients, median age 4.5 years
1.4-44 years), median weight 16 kg (9.4-94 kg), underwent a primary extracardiac
onduit Fontan procedure. Early and late outcomes were analyzed for the entire
ohort and for 2 patient groups depending on whether an oxygenator was used in the
ypass circuit (166 patients; 58%) or not (119 patients; 42%).
esults: Early failure (including death and takedown) occurred in 7 patients (2.5%).
revalence of new early postoperative sinus node dysfunction necessitating a
ermanent pacemaker was 0.4%, and that of new tachyarrhythmias necessitating
ischarge home on a regimen of antiarrhythmia medications was 2.5%. Ten-year
ctuarial freedom from Fontan failure, new sinus node dysfunction necessitating a
ermanent pacemaker, and reoperation for conduit thrombosis or stenosis was 90%,
6%, and 98%, respectively. Fenestration rate was lower (P  .001) in the
o-oxygenator group (8%) than in the oxygenator group (25%). Patients in the
o-oxygenator group had lower intraoperative Fontan pressure (12.0  2.3 vs
3.5  2.4 mm Hg, P  .001), common atrial pressure (4.6  1.8 vs 5.3  1.8 mm
g, P  .003), and transpulmonary gradient (7.5  2.1 vs 8.3  2.2 mm Hg, P 
013) than did the oxygenator group.
onclusions: The extracardiac conduit Fontan operation coupled with minimal use
f extracorporeal circulation is associated with favorable intraoperative hemody-
amics, low fenestration rate, minimal risk of thrombosis or stenosis, and minimal
arly and late rhythm disturbance.
he optimal Fontan connection requires a combination of factors that, when
viewed in light of the dichotomy of the currently available options between
the lateral tunnel (LT) and extracardiac conduit (EC) Fontan operations, arerequently conflicting. Among these factors are the provisions for growth potential,
iovascular Surgery ● November 2006
at
t
a
g
o
o
o
t
h
i
t
t
r
o
f
s
a
o
s
l
t
w
P
T
u
A
a
p
t
g
s
p
c
t
n
o
t
a
c
p
b
a
v
D
f
a
c
w
F
E
c
C
l
o
p
d
P
M
c
T
p
t
m
q
o
c
a
r
d
a
c
c
fl
w
f
r
A
W
t
S
t
a
a
o
t
c
W
p
P
I
o
b
a
Petrossian et al Surgery for Congenital Heart Disease
CH
Dvoidance of atrial surgery, and avoidance of atrial disten-
ion. We believe that the rhythm-stabilizing advantages of
he EC Fontan, related to avoidance of atrial surgery and
trial distention, outweigh its disadvantage related to lack of
rowth potential, which can be controlled for by doing the
peration at an older age. This study in part is a report of our
verall early and midterm experience with the EC Fontan
peration and examines the evidence for and against this
echnique.
Given the inherently marginal nature of the post-Fontan
emodynamics related to lack of a pulmonary ventricle,
mproved early postoperative outcomes require optimiza-
ion of perioperative cardiac output and reduction of sys-
emic venous/Fontan pressure. This can be achieved by
educing the inflammatory and ischemic stresses of the
peration and by fenestrating the Fontan circuit. Fontan
enestration, however, has both short- and long-term con-
equences, and with the EC technique, it requires limited
dditional atrial surgery. Instead, we have chosen to focus
n minimizing the perioperative inflammatory and ischemic
tresses by continuing to modify the extracorporeal circu-
atory support associated with the operation. This study is
herefore also a report of our evolving technique and results
ith the minimal approach extracorporeal circulation.
atients and Methods
his is a retrospective analysis of 302 consecutive patients who
nderwent an EC Fontan operation between September 1992 and
pril 2005. Of these, 285 patients underwent a primary Fontan,
nd 17 had revision of an atriopulmonary or LT Fontan to an EC
rocedure. The 285 patients who underwent a primary Fontan are
he focus of this study. All operations were performed by a single
roup of pediatric cardiac surgeons with an internally consistent
trategy. All patients underwent an extracardiac connection. The
atients’ preoperative management was designed to avoid con-
omitant intracardiac procedures by performing them at the time of
he bidirectional Glenn or at a separate procedure. To reduce the
eed for reoperation for Fontan pathway obstruction related to lack
f conduit growth potential, the operation was not performed until
he patient reached a weight of about 15 kg (about 3-5 years of
ge), so that a large, at least 18-mm and more commonly a 20-mm
onduit could be inserted. Intraoperative management centered on
Abbreviations and Acronyms
ASA  acetylsalicylic acid
CPB  cardiopulmonary bypass
EC  extracardiac conduit
IVC  inferior vena cava
LT  lateral tunnel
PA  pulmonary artery
PTFE  polytetrafluoroethylene
SVC  superior vena cavaerforming a large pulmonary artery (PA) anastomosis using a n
The Journal of Thoraciceveled conduit and incorporating it into aggressive pulmonary
rterioplasties. Care was taken to avoid PA, conduit, and inferior
ena cava (IVC) distortion and pulmonary venous compression.
uring the mediastinal dissection, the sinus node area was care-
ully identified and direct trauma and traction on the node were
voided. The circulatory support technique evolved over the
ourse of our experience. Four different circulatory techniques
ere used.
ull Cardiopulmonary Bypass (CPB): 1992 to 1998
arly in our experience, the entire operation, including the
onduit-PA and conduit-IVC anastomoses, was performed on full
PB. The aorta, superior vena cava (SVC), and IVC were cannu-
ated, and an oxygenator was used in the bypass circuit. From the
utset, induced cardiac arrest was avoided and the operation was
erformed on a warm beating heart unless a concomitant intracar-
iac operation was necessary.
artial CPB: 1998 to 2000
idway in our experience, we realized that the PA anastomosis
ould be safely performed without the need for circulatory support.
he PA anastomosis site was first isolated with vascular clamps
laced toward the contralateral lung and immediately adjacent to
he Glenn anastomotic site, such that adequate Glenn flow was
aintained to the ipsilateral lung. Care was taken to ensure ade-
uate oxygenation and ventilation by monitoring the systemic
xygen saturation and end-tidal carbon dioxide level and by taking
are to avoid obstruction of SVC blood flow. In patients who had
jugular central venous line in place, with the PA clamps tempo-
arily in place, the Glenn pressure was monitored to ensure that it
id not go above 15 to 20 mm Hg. The clamps were accordingly
djusted before committing to the incision and anastomosis. After
ompletion of the PA anastomosis, the conduit was clamp oc-
luded and the PA clamps were removed, re-establishing Glenn
ow to both lungs. The aorta and IVC were then cannulated, and
ith an oxygenator in the circuit, the IVC anastomosis was per-
ormed on partial warm CPB. With this technique, CPB times were
educed dramatically to about 10 to 20 minutes.
ctive IVC Decompression: 2000 to 2002
ith further experience it became evident that safe performance of
he IVC anastomosis did not require the use of an oxygenator.
ince oxygenation and ventilation were maintained by Glenn flow
o the lungs, only a pump was necessary to decompress the IVC
nd support systemic blood flow. After completion of the PA
nastomosis, the aorta and IVC were cannulated and, without an
xygenator in the circuit, the IVC blood was drained and pumped
o the aorta with either a roller pump or, more commonly, a
entrifugal pump during performance of the IVC anastomosis.
ith this technique, the oxygenator was completely avoided and
ump times remained low in the 10- to 20-minute range.
assive IVC Decompression (Off-pump): 2002 to 2005
n the most recent phase of our experience with the EC Fontan
peration, the pump was also eliminated, allowing the operation to
e performed completely off-pump. After completion of the PA
nastomosis, the IVC and right atrium were cannulated and con-
ected to each other directly, allowing passive lower body venous
and Cardiovascular Surgery ● Volume 132, Number 5 1055
d
f
r
g
a
s
a
t
n
w
o
a
e
4
D
I
s
h
t
c
t
o
p
T
h
b
t
d
l
c
r
s
s
S
a
n
t
c
T
v
o
3
a
a
m
a
s
a
c
R
M
w
w
l
d
t
o
p
l
u
w
u
t
s
l
B
c
i
d
2
f
t
b as a
s
fi
1
s
a
w 1).
I
c
a were
n
e
t
t
b
r
a
s
o
t
o
a
T
c
o
C
Surgery for Congenital Heart Disease Petrossian et al
1
CH
Decompression during the IVC anastomosis. In patients with a
emoral central venous line in place, with the IVC clamps tempo-
arily in place, the pressure was monitored to ensure that it did not
o above 15 to 20 mm Hg. If necessary, the patient was placed in
mild Trendelenburg position to aid lower body drainage. Mild
ystemic hypotension was treated with volume administration.
Fenestrations were never routinely performed, but they were
dded to the procedure when the surgeon deemed them important
o patient outcome. After completion of the operation, hemody-
amic status was evaluated intraoperatively. If Fontan pressure
as consistently above 18 mm Hg, with a transpulmonary gradient
f 12 mm or more, a fenestration was placed between the conduit
nd the right atrial free wall. This was accomplished without CPB,
ither with a direct 4- to 6-mm side-to-side anastomosis or with a
- to 8-mm polytetrafluoroethylene (PTFE) tube graft.
ata Collection and Follow-up
nstitutional review board approval for a retrospective clinical
tudy was obtained. Perioperative data were obtained by review of
ospital medical records. Late follow-up data were obtained from
he patients’ cardiologists or pediatricians. Follow-up information
ollected included copies of physician clinic notes, resting elec-
rocardiogram, ambulatory rhythm monitor, echocardiogram, and
ther diagnostic information as indicated. The early postoperative
eriod was defined as the time from surgery to hospital discharge.
he late postoperative period was defined as the time from initial
ospital discharge to latest follow-up. Late arrhythmia data were
ased on the patients’ histories of symptoms and follow-up elec-
rocardiograms. There was no protocol for systematic arrhythmia
etection such as regularly scheduled Holter monitoring. Early and
ate outcome variables were compared among the four different
irculatory support categories. Data analysis in these four catego-
ies revealed that the full CPB subgroup and the partial CPB
ubgroup showed no major differences in outcome. Thus these two
ubgroups were combined into one group, the oxygenator group.
imilarly, the active IVC decompression (pump only) subgroup
nd the passive IVC decompression (off-pump) subgroup showed
o major differences; thus they were combined into another group,
he no-oxygenator group. Early and late outcome variables were
ompared between the oxygenator and no-oxygenator groups.
here were no significant differences in age, sex, weight, dominant
entricle, prevalence of heterotaxy, or conduit size between the
xygenator and no-oxygenator groups. Mean follow-up time was
ABLE 1. Distribution of patients among the four different
irculatory strategies and in the oxygenator and no-
xygenator groups
Circulatory Strategy No. (%)
Oxygenator group 166 (58)
Full CPB 115 (40)
Partial CPB 51 (18)
No-oxygenator group 119 (42)
Active IVC decompression 66 (23)
Passive IVC decompression 53 (19)
PB, Cardiopulmonary bypass; IVC, inferior vena cava..7 years (0.1-11.7 years). At least one postdischarge follow-up was a
056 The Journal of Thoracic and Cardiovascular Surgery ● Novvailable in 96% of the patients. A total of 12,206 patient-months of
ctual follow-up were available. Ratio of actual to potential follow-up
onths yielded an 85% completeness of follow-up. Continuous vari-
bles between the two groups were compared with independent
amples t test. Correlation between two continuous variables was
ssessed with linear regression analysis. Freedom from event was
alculated by Kaplan-Meier survival estimates.
esults
edian age was 4.5 years (1.4-44 years) and median weight
as 16 kg (9.4-94 kg). In 45 patients (16%), the operative
eight was less than 14 kg, and in 20 patients (7%), it was
ess than 13 kg. The morphologic characteristic of the
ominant ventricle was that of right or indeterminate ven-
ricle in 102 of 282 patients (36%) and that of a left ventricle
r combined unseptatable left and right ventricles in 180
atients (64%). A PTFE conduit (Gore-Tex Stretch Vascu-
ar Graft; W. L. Gore & Associates, Inc, Flagstaff, Ariz) was
sed in 270 of 285 patients (95%). Early in our experience,
e used homograft tissue in 12 patients. Three patients
nderwent autologous tissue extracardiac Fontan by anas-
omosing the main PA directly to the IVC. Median conduit
ize was 20 mm (16-24 mm). Conduit size was 18 mm or
arger in 97% of the patients and 20 mm or larger in 69%.
y definition, no patients in the no-oxygenator group had a
oncomitant intracardiac operation. By contrast, 10 patients
n the oxygenator group (6%) had a concomitant intracar-
iac operation. Crossclamping of the aorta was avoided in
71 patients (95%). The PA-conduit anastomosis was per-
ormed off-pump, before the IVC anastomosis, in 174 pa-
ients (65%). Distribution of patients among the different
ypass strategy groups is depicted in Table 1. There w
ignificant difference in the rate of oxygenator use in the
rst 143 cases (87%) in our series compared with the last
42 cases (30%) (P  .001). In the oxygenator group, a
ignificant correlation was found between duration of CPB
nd intraoperative Fontan pressure; longer CPB duration
as associated with higher Fontan pressure (Figure 
ntraoperative hemodynamic data including Fontan and
ommon atrial pressures and transpulmonary gradients were
ll lower in the no-oxygenator group (Table 2). There 
o differences in these parameters within the subgroups of
ither the oxygenator or no-oxygenator groups. Early mor-
ality occurred in 3 patients (1.1%). The circulatory support
echnique used in these patients was full CPB. There have
een no deaths in our last 186 patients. Four patients (1.4%)
equired early Fontan takedown on postoperative days 0 to 4,
nd survived. Three of these patients underwent a second
uccessful Fontan operation 1 to 4 years after their initial
peration. Early Fontan failure rate (including death and
akedown) was therefore 2.5%. All of the Fontan failures
ccurred in the oxygenator group. There were no perioper-
tive cerebral events, hepatic injury, cardiac ischemia, or
rrhythmias attributed to the limited extracorporeal tech-
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Dique. There were no patients in the partial CPB, active IVC
ecompression, or passive IVC decompression groups who
equired conversion to full CPB because of difficulty with
ompletion of the anastomoses. One patient in the passive
VC decompression group was subsequently found to have
leeding from the PA anastomosis and was placed on full
PB for repair. Four patients (1.4%) had early Fontan
hrombosis 3 to 5 days postoperatively, necessitating reop-
ration and thrombectomy. Two of these events occurred in
he oxygenator group and 2 in the no-oxygenator group. The
irculatory support techniques used included full CPB in 2
atients, active IVC decompression in 1 patient, and passive
VC decompression in 1 patient. One of these patients
nderwent an autologous tissue direct PA-IVC anastomosis
ithout use of a conduit. Anastomotic suture-line tension
as suspected as the cause of the thrombosis. At reoperation,
PTFE graft was inserted. The second patient was 2.3 years
ld and weighed 12.5 kg. A 20-mm conduit was initially
nserted. After thrombosis on postoperative day 4, presum-
bly caused by patient-conduit size mismatch, the conduit
as removed and was replaced with an 18-mm conduit. The
hird patient was a 13.2-kg patient who received a 20-mm
onduit. Fontan thrombosis occurred on postoperative day 3
igure 1. Correlation between CBP time and intraoperative Fon-
an pressure (regression coefficient 5.5, P .01). OR, Operating
oom; CPB, cardiopulmonary bypass.
ABLE 2. Intraoperative hemodynamic data in the oxygen-
tor versus no-oxygenator groups
emodynamic data Oxygenator No-oxygenator P value
ontan pressure 13.5 2.4 12.0 2.3 P  .001
ommon atrial pressure 5.3 1.8 4.6 1.8 P  .003
ranspulmonary gradient 8.3 2.2 7.5 2.1 P  .013
ll pressures are expressed in millimeters of mercury  standard
geviation.
The Journal of Thoracicfter administration of blood products at the time of reop-
ration for evacuation of a substernal hematoma. The fourth
atient had marginal preoperative ventricular diastolic func-
ion with an end-diastolic pressure of 14 mm Hg and had
ow cardiac output postoperatively. There was no mortality
r Fontan takedown in these 4 patients. A nonobstructive
hrombus was detected on echocardiogram in 1 other patient
efore hospital discharge. It was treated with anticoagula-
ion and resolved.
Forty-nine patients underwent intraoperative fenestra-
ions. Of these procedures, 14 were side-to-side anastomo-
es and 31 were PTFE tube grafts (preferred technique). In
patients the fenestration type was not indicated in the
perative report. Most intraoperative fenestrations were per-
ormed early in our experience between 1992 and 1995.
ince 1995, intraoperative fenestration was used in only 24
9.7%) of 247 patients undergoing an EC Fontan procedure.
enestration rate was lower (P .001) in the no-oxygenator
roup (9 patients, 8%) than in the oxygenator group (40
atients, 25%). At the extremes of circulatory management,
he full CPB subgroup had the highest fenestration rate of
4%, whereas the fenestration rate in the latest subgroup of
assive IVC decompression was 8% (P  .001).
Ninety-six percent of patients had preoperative sinus or
onsinus atrial rhythm. Among 278 patients who survived
o hospital discharge with a functional Fontan (excluding
arly deaths and takedowns), 95% were in sinus or nonsinus
trial rhythm. Fixed (nontransient) sinus node dysfunction
ecessitating early postoperative implantation of a perma-
ent pacemaker occurred in 1 patient (0.4%). Two other
atients required a pacemaker for postoperative complete
eart block (1 after ventricular septal defect enlargement).
ive other patients underwent a planned intraoperative
acemaker insertion for preoperatively diagnosed dysrhyth-
ias. Seven patients (2.5%) had recurrent (nontransient)
ewly diagnosed early postoperative supraventricular tachy-
rrhythmias necessitating discharge home on a regimen of
ntiarrhythmia medications: 3 with junctional tachycardia,
with atrioventricular tachycardia, 1 with intra-atrial reen-
rant tachycardia, and 1 with atrial fibrillation.
Of 259 patients in whom information was available, 200
77%) were extubated within 24 hours after the operation.
ther hospital milestones are listed in Table 3. Duratio
hest tube drainage was longer (P  .003) in the full CPB
ABLE 3. Hospital milestones
ilestone Value
entilator duration less than 24 h 77%
notropic support less than 48 h 70%
edian chest tube duration (d) 8 (range 2-91)
edian hospital stay (d) 11 (range 4-106)roup (11.8  12.0 days) than in the passive IVC decom-
and Cardiovascular Surgery ● Volume 132, Number 5 1057
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Dression (off-pump) group (7.8  3.5 days). There were no
ther differences in early outcome variables between the
xygenator and no-oxygenator groups or their subgroups.
hest tube drainage lasting more than 14 days occurred in
5% of the patients. Although somewhat variable, the gen-
ral criteria for chest tube discontinuation was drainage of
ess than 1 to 2 mL · kg1 · d1 for 2 consecutive days.
mong survivors to hospital discharge, 2 patients (1.1%)
ad an early postoperative cerebrovascular accident. Two of
hese patients underwent surgery on full CPB, and 1 patient
ABLE 4. Predischarge and follow-up anticoagulant and
ntiplatelet management
egimen Predischarge (%) Follow-up (%)
arfarin only 50 10
SA only 17 74
arfarin and ASA 30 8
o warfarin or ASA 3 8
SA, Acetylsalicylic acid.
ABLE 5. Late outcomes
Outcome No.
Mortality 8
Fontan takedown 1
Cardiac transplantation 1
Intracardiac thrombi 5
Cerebrovascular accident 3
Protein-losing enteropathy 3
Plastic bronchitis 3
Late pacemaker for sinus node dysfunction 5
Late-onset supraventricular tachyarrhythmia 4058 The Journal of Thoracic and Cardiovascular Surgery ● Novad active IVC decompression. Neither of these patients had
fenestration. Predischarge room-air median oxygen satu-
ation (including patients with patent fenestrations) was
6% (75%-99%). Ninety-seven percent of the patients were
ischarged home on a regimen of acetylsalicylic acid (ASA)
r warfarin or both (Table 4).
ate Postoperative Data
ate outcomes are summarized in Table 5. Three pat
ith early mortality and 1 patient with early Fontan failure
ecessitating permanent takedown are excluded from the
enominator in the late data analysis. Three other patients
ho had a second successful Fontan after initial takedown
ere counted only once (since the first operation) in the late
ata analysis. A total of 278 patients were therefore avail-
ble for late analysis. Late mortality occurred in 8 of 278
atients (2.9%), from 3 months to 8 years after the initial
peration (mean 2.4 years). Late Fontan takedown was
equired 3.4 years after the initial operation in 1 patient with
rotein-losing enteropathy. One heterotaxy patient under-
ent successful cardiac transplantation for worsening ven-
ricular failure 4 months after the initial operation. Ten-year
ctuarial freedom from Fontan mortality was 91%, and
reedom from Fontan failure (including mortality, take-
own, and cardiac transplantation) was 90% (Figure 2)
There were no cases of late Fontan conduit thrombosis or
tenosis necessitating reoperation. One patient in the pas-
ive IVC decompression group underwent repair of right PA
tenosis during reoperation for atrioventricular valve regur-
itation 23 months postoperatively. Ten-year actuarial free-
om from reoperation for conduit thrombosis or stenosis was
8%. Late intracardiac thrombi were detected in 5 patients
1.8%) 2 months to 5 years postoperatively. Of these, 3 were in
Figure 2. Actuarial freedom from Fontan
failure including mortality, takedown,
and cardiac transplantation. Vertical
bars indicate 70% confidence limits (CL).
Numbers of patients at risk are shown in
parentheses.ember 2006
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Dhe systemic venous side, 1 was in the pulmonary venous side,
nd 1 was in the neoaortic root. Late cerebrovascular accident
ccurred in 3 patients 2 months to 9 years after the operation.
rotein-losing enteropathy occurred in 3 patients and plastic
ronchitis developed in 3 other patients (Table 5).
At follow-up, 91% of the patients were in sinus or
onsinus atrial rhythm. Excluding 11 nonsurvivors, 3 sur-
ivors with early or late failure, 5 patients with pre-existing
acemakers, and 5 patients with planned intraoperatively
mplanted pacemakers, there were 262 patients available for
hythm analysis. Among these 262 patients, late rhythm
nformation was available in 247 patients (95%). Among
hese 247 patients, the incidence of late sinus node dysfunc-
ion requiring insertion of a pacemaker was 2% (5 patients).
en-year actuarial freedom from needing a pacemaker for
inus node dysfunction was 96%. Two patients were asymp-
omatic with chronic stable junctional rhythm and did not
equire pacemaker insertion. Three patients required a
acemaker for late-onset heart block. Excluding patients
ith pre-existing tachyarrhythmias, 4 patients (1.6%) had
dentified late-onset supraventricular tachyarrhythmias.
t follow-up, 6 patients (2.3%) were receiving long-term an-
iarrhythmia medications for new or pre-existing supraventric-
lar tachyarrhythmias.
There were no significant differences between the oxy-
enator and the no-oxygenator groups for any of the above
ate outcome measures. At a mean follow-up time of 3.7
ears, 90% of the patients were in New York Heart Asso-
iation functional class I, 9% were in class II, 0.4% were in
lass III, and none were in class IV. Late follow-up echo-
ardiogram was available in 248 of 268 late survivors with
functional Fontan (excluding 3 with early Fontan failure
ho underwent successful reoperation). Among these 248
atients, ventricular function was graded qualitatively as
ormal or adequate in 237 patients (96%), whereas 3% had
ild dysfunction and 1% had moderate or severe dysfunc-
ion. Late oxygen saturation was available in 185 patients.
edian room-air oxygen saturation was 96% (73%-100%).
his included patients with a patent fenestration. Break-
own of patients on the basis of type of anticoagulation
egimen at follow-up is provided in Table 4. Ninety
ercent of the patients were receiving ASA or warfarin or
oth. The referring cardiologist managed the patients’ anti-
oagulation after hospital discharge.
iscussion
he current options for long-term palliation of patients with
unctional single ventricle hearts remain primarily limited to
he LT and the EC Fontan operations. Both procedures have
istinct advantages and disadvantages that, given today’s
echnology, cannot yet be consistently incorporated into a
ingle operation. Since all of the patients in the current study
ad EC Fontan operations, direct comparison of the two i
The Journal of Thoracicrocedures is not possible from the information provided in
his analysis. The study, however, does provide useful in-
ormation addressing the various unproved claims, both in
raise and in criticism, that have been made in relation to
he EC Fontan operation.
The early and midterm Fontan failure rate, intraoperative
emodynamics, early and late outcomes, and midterm qual-
ty of life data all support the conclusion that the EC Fontan
peration is a safe and reliable procedure that provides a
urable and functional conduit. Favorable results with the
C Fontan have also been reported by several other cen-
ers.1-4 A potential disadvantage of the EC Fontan opera
s related to the lack of growth potential incorporated into
he circuit.5 In our experience, this issue has been ef-
ively dealt with by waiting to perform the operation until
he patient reaches a weight of about 15 kg (about 3-5 years
f age), so that a near adult IVC–sized conduit (18 mm in
7% of our cases) can be inserted. This strategy is designed
o minimize the potential for radial outgrowth of the conduit
nd to accommodate the patient’s future exercise demands.
he potential for axial distortion with patient growth seems
t least as likely with the PTFE baffle used in the LT as it
s with an EC Fontan operation. Although long-term data
re not available, to our knowledge none of our patients has
equired conduit replacement for growth-related pathway
bstruction. Delaying the Fontan operation until 3 to 5 years
f age incurs minimal additional risk. Worsening cyanosis
oes not generally develop until later, when patients start
sing more extensive lower body exercise and the head/
ower body size ratio decreases further. For patients oper-
ted on before about 5 years of age, preoperative compli-
ations related to cyanosis and right-to-left shunt have been
xtremely uncommon in our series and have not justified
arlier operation. Excluding patients who were referred for
urgery at a much later age, development of clinically
ignificant pulmonary arteriovenous malformations has
een rare.
Another potential disadvantage of the EC Fontan opera-
ion, in the view of some, is the possibility of an unaccept-
ble incidence of thrombosis. It is acknowledged by all that
ultiple factors including obligatory foreign material, sys-
emic coagulation profile, nonpulsatile flow, and stasis re-
ated to lower postoperative cardiac output that may exist in
ll patients with a functional single ventricle after a Fontan
peration, whether EC or LT, put them at higher risk for
lotting problems; however, there seems to be no basis for
he position that the EC Fontan is a greater risk. The area of
oreign body in contact with the bloodstream might seem at
rst to be higher with the EC; however, it is important to
ote that the LT baffle is in contact with the blood twice, on
oth the left side and the right, so that the total area of
ontact is roughly similar between the EC and the LT. An
mportant corollary to this is that the LT exposes both the
and Cardiovascular Surgery ● Volume 132, Number 5 1059
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Dystemic and pulmonary circulations to the risk of foreign
ody–related thromboembolic complications, whereas with
he EC the risk is confined to the pulmonary circulation.
Our experience supports the position that the risk of both
arly and midterm thrombosis is low for the EC Fontan,
ith freedom from reoperation of 98% at 10 years. Of the 4
ases of thrombosis necessitating reoperation, all occurred
n the early postoperative period, with no late occurrence.
ne of the cases was technical and did not involve a
onduit; it is not relevant to our current technique. This
atient received a primary IVC-PA anastomosis, which was
nder tension. Of the 3 patients with PTFE grafts, 1 was
onsidered a very high-risk candidate because of ventricular
iastolic dysfunction, suggesting a hemodynamic cause re-
ulting in low cardiac output and stasis. The other 2 patients
eceived 20-mm conduits, despite having body weights of 12
nd 13 kg. This suggests that patient weight–conduit diameter
ismatching (oversizing) may be causative.6 Careful attention
o patient selection and appropriate graft sizing should reduce
ven further the already low incidence of early postoperative
raft thrombosis. Beyond the early postoperative period,
nly 5 patients in our series were found to have intracardiac
hrombi. Of these thrombi, 3 were in the systemic venous
ide, 1 in the pulmonary venous side, and 1 in the neoaortic
oot. These results compare favorably with the incidence of
ost-Fontan thromboembolic events reported in the litera-
ure.7-10 Our prophylactic strategy has been warfarin al
r in combination with ASA for the vulnerable first 3
onths postoperatively to allow for endothelialization of
he suture lines. This is then followed by lifelong ASA
herapy with yearly transthoracic echocardiographic
onitoring.
Institutions that perform primarily an LT have reported
avorable overall results with the Fontan operation.11-13
trial arrhythmias, however, continue to be a concern with
he LT technique. In one large series of exclusively LT
ontan operations, freedom from new bradyarrhythmias
as 79% at 10 years.11 Our data show a high incidence
ither sinus rhythm or nonsinus atrial rhythm, both early and
idterm, and low incidences of new-onset pacemaker
lacement and supraventricular tachyarrythmias necessitat-
ng antiarrhythmia medications. Although the outcome vari-
bles examined are different between studies, these results
ompare favorably with reports in the literature on rhythm
isturbance after the LT Fontan11,14 and are supported b
ther centers performing the EC Fontan.2,4,15 There are
mportant rhythm-related differences between the two tech-
iques. The LT Fontan involves extensive atrial surgery,
ncluding in the vicinity of the sinus node and crista termi-
alis, whereas the EC Fontan involves minimal atrial sur-
ery, confined to the IVC transection site, an area that is
emote from the sinus node. Furthermore, after the LT
ontan, a portion of the right atrium, including the sinus a
060 The Journal of Thoracic and Cardiovascular Surgery ● Novode and crista, is suddenly exposed to the higher-pressure
ontan circuit, whereas after the EC Fontan, the entire
trium is in contact with the low-pressure pulmonary ve-
ous circuit. Avoidance of pressure-related atrial stretch on
he sinus node and crista, along with the minimal atrial
ncisions and suture lines associated with the EC Fontan,
ay possibly avoid the long-term electrophysiologic sub-
trates for development of atrial arrhythmias.
An important principle of the Fontan operation is to
chieve a nonobstructive Fontan pathway. Pathway obstruc-
ion is more frequently an issue at the superior (PA) and at
he Fontan connection. The main objectives are to create a
arge PA anastomosis and to avoid branch PA stenosis. An
T Fontan performed after, or incorporating, a hemi-Fontan
ype operation (which creates a large superior connection) is
requently nonobstructive. The same cannot be said with
ertainty regarding an LT connection through the cardiac
nd of the SVC or the roof of the atrium, after a previous
idirectional Glenn. The price to be paid for a hemi-Fontan,
owever, is the need for significant atrial surgery in the
icinity of the sinus node and potential long-term arrhyth-
ogenicity.14 The EC Fontan, on the other hand, can
one after, or incorporating, the technically simple and less
nvasive bidirectional Glenn, and it can be performed with
large PA anastomosis incorporated into PA plasties,
hereby achieving a nonobstructive superior connection,
ithout the need for atrial surgery. In our series, only 1
atient required additional surgery for branch PA stenosis,
t the time of planned surgery for atrioventricular valve
egurgitation.
Given the inherently marginal nature of the post-Fontan
emodynamics related to lack of a pulmonary ventricle,
mproved early postoperative outcomes require optimiza-
ion of perioperative cardiac output and reduction of sys-
emic venous/Fontan pressure. This can be achieved by
enestrating the Fontan circuit and by reducing the inflam-
atory and ischemic stresses of the operation. We have
hosen to focus on the latter by continuing to modify the
xtracorporeal circulatory support associated with the oper-
tion. From the outset, we avoided ischemic arrest of the
eart, unless occasionally necessitated by a concomitant
ntracardiac procedure. Our circulatory support manage-
ent gradually evolved into the four support techniques
escribed. We initially used full CPB, then transitioned to
artial CPB with IVC cannulation only, then eliminated the
xygenator but kept the pump (active IVC decompression),
nd finally eliminated the pump as well (passive IVC de-
ompression, or “off-pump”). Thus, the opportunity exists
o examine the outcomes of an operation performed quite
niformly in essentially all respects, with the exception of a
ide spectrum of circulatory support techniques. The four
roups were then consolidated into two—the oxygenator
nd no-oxygenator groups. Further comparisons between
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Dhe oxygenator and the no-oxygenator groups showed a
umber of important differences, and thus this categoriza-
ion of patients became the basis for further analysis. It
hould be emphasized from the outset, however, that the
roups are not fully matched for comparison for several
easons. The groups are not contemporaneous, and the pa-
ients were not prospectively randomized to the various
irculatory support techniques, but rather the technique was
radually modified over time and experience, based on
erceived overall benefit to the patient. In addition, in the
xygenator group, 10 patients (6%) underwent a concomi-
ant intracardiac operation, whereas in the no-oxygenator
roup, by definition, no patients had a concomitant intra-
ardiac procedure. These issues create distinct limitations
or interpreting the data and introduce potential bias; nev-
rtheless, a number of interesting and potentially important
nsights can be gained by the analysis of the experience.
The transition from full to partial CPB dramatically
educed the bypass times and afforded a wide spectrum of
PB times with which to assess Fontan hemodynamics.
here was a direct correlation between CPB time and higher
ontan pressure (Figure 1). Comparison of the oxygen
nd no-oxygenator groups revealed that the Fontan pres-
ure, common atrial pressure, and transpulmonary gradient
ere all higher in the oxygenator group (Table 2). All 
arly Fontan failures occurred in the oxygenator group.
enestration rate was considerably higher in the oxygenator
roup (25%) than in the no-oxygenator group (8%), with the
ighest rate being in the full CPB subgroup (34%). These
esults agree with those of several studies that show the length
f CPB to be associated with worse early outcomes.2,3,13,16,17
lthough these observed differences should be viewed with
aution given the inherent differences between the groups, it
an be argued that elimination of the oxygenator certainly did
ot result in worse outcomes, but it may not have been the only
actor that contributed to the improved outcomes. The ob-
ervation that important differences are present in a variety
f early outcome measures between the oxygenator group
nd the no-oxygenator group, but that there are no differ-
nces in these same outcome measures between the two
ubgroups that made up the no-oxygenator group (the active
VC decompression subgroup and the passive IVC decom-
ression subgroup), suggests that elimination of the oxy-
enator is important but elimination of the pump is not.
The feasibility of performing the EC Fontan operation
ith limited extracorporeal support should be evaluated
ndividually in each patient depending on the anatomy.
egarding the conduit-PA anastomosis, important factors to
onsider are the relative position of the Glenn connection
central versus eccentric) with respect to the branch PAs, the
ize of the branches, and the presence or absence of impor-
ant branch PA stenosis. At the most favorable extreme, an
ccentrically positioned Glenn with large nonstenotic t
The Journal of Thoracice
ranch PAs is best suited for an off-pump technique,
hereas a centrally placed Glenn with bilateral branch PA
tenoses is not. The final determinant of suitability of an
ff-pump approach is the avoidance of intraoperative oxy-
en desaturation, low end-tidal carbon dioxide readings, or
erebral venous hypertension during temporary clamp oc-
lusion of the PAs. Since the conduit-PA anastomosis is
erformed toward the lung contralateral to the Glenn con-
ection (while the Glenn perfuses the ipsilateral lung), off-
etting of the Glenn and Fontan anastomoses is a natural
onsequence of the off-pump technique. The IVC anasto-
osis does not require special maneuvers, as it is performed
n a similar manner whether accomplished on-pump or
ff-pump. The determinant of suitability of the off-pump
echnique is the avoidance of important hypotension during
emporary clamp occlusion of the IVC while the IVC–right
trial shunt is open. Mild degrees of hypotension can be
ealt with by placing the patient in a Trendelenburg position
o aid lower body drainage and administration of volume.
It has been argued that routine Fontan fenestration im-
roves early postoperative outcomes.12,18,19
At institutions that have primarily performed an LT
ontan, a large majority of the patients are discharged home
ith a fenestration.11-13 In contrast, fenestration rate in o
ast 247 patients has been less than 10%. Fenestration rate as
ow as 15% has also been reported with the EC Fontan
peration performed with a short mean duration of full
PB.3 We would agree that if the Fontan completion 
o be done with prolonged full extracorporeal support, hy-
othermia, ischemic cardiac arrest, and total circulatory
rrest, a fenestration would be a more frequent necessity,
ith either the LT or the EC Fontan. This has also been the
ase early in our experience when the operation was per-
ormed on full CPB with more prolonged bypass times
ssociated with the early learning curve and more frequent
ntracardiac procedures.20 The extracardiac nature of the E
ontan operation, however, allows for the operation to be
erformed with a variety of bypass techniques and avoid-
nce of ischemic cardiac arrest. Our approach has been to
ake full advantage of this flexibility and to minimize ex-
racorporeal support to the extent possible. This approach
as helped in achieving favorable early postoperative out-
omes without the need for a fenestration. Short- and long-
erm postoperative issues related to a patent fenestration,
ncluding cyanosis, potential complications related to a
ight-to-left shunt, and need for an additional procedure to
lose the fenestration, are therefore avoided. It should also
e mentioned that with the EC Fontan technique, there is a
istinct incentive to avoid a fenestration. Fenestrating an EC
equires a limited amount of additional atrial surgery (with
ither a side-to-side or a tube graft fenestration). Since
voiding atrial surgery is one of the important advantages of
he extracardiac technique, optimizing the intraoperative
and Cardiovascular Surgery ● Volume 132, Number 5 1061
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Demodynamics in an attempt to avoid the need for a fenes-
ration has been a natural consequence of our commitment
o the EC Fontan operation.
In the current study, there were no important differences
etween the oxygenator group and the no-oxygenator group
or any late outcome measures, implying that the influence
f circulatory support technique is much greater in the
erioperative period and this influence fades as time after
urgery increases.
onclusions
he EC Fontan procedure is a safe, reliable, and effective
odification of the Fontan operation. This study supports
he view that this procedure provides a unique benefit by
inimizing early and possibly also midterm atrial rhythm
isturbances, as well as the view that concerns over a high
ate of growth-related conduit obstruction and conduit
hrombosis are unwarranted. The EC Fontan operation also
rovides the unique opportunity for maximal flexibility with
espect to the circulatory support methods used in the op-
ration. Avoidance of an oxygenator seems to confer a
umber of early benefits, including improved hemodynam-
cs and a reduced need for fenestration. In contrast, presence
r absence of a pump appears to have no effect on early
utcome. The operation can therefore be performed either
ff-pump or with active IVC decompression using a pump,
t the discretion of the operating surgeon, with equal
enefit.
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iscussion
r Marshall L. Jacobs (Philadelphia, Pa). With this superb series
f EC Fontan procedures, Dr Hanley’s group has set the bar high
ith respect to operative outcomes. Emphasis has been placed on
ncreasing independence from CPB or partial circulatory support
ver the course of the series. In the manuscript, the authors
cknowledge that the influence of circulatory support strategy is
ntirely in the early perioperative period. The principal hemody-
amic benefit of avoiding bypass appears to be a decrement of
pproximately 1 mm Hg in the atrial pressure, the transpulmonary
radient, and the venous pathway pressure at the end of the
peration.
There is no question as to the quality of these outcomes; they
re excellent. One could stand here and present a series of com-
arable outcomes with Fontan operations using different means of
ardiopulmonary support or different means of constructing the
otal cavopulmonary connection, but that would not make for an
nteresting discussion. What it would do is to raise an interesting
uestion. There is clearly no question that a no-bypass strategy
imits the surgeon’s choice to that of EC Fontan only, eliminating
he possibility of an intra-atrial tunnel reconstruction. One must
ecide, then, whether the EC Fontan is the optimal palliation for all
unctional univentricular hearts. If not, does avoidance of bypass
ustify limiting the scope of surgery to this one type of reconstruc-
ion?
In 1999, Fogel at the University of Pennsylvania used magnetic
esonance pulse labeling to study the distribution of venous flow to
he right and left PAs in patients on whom we had performed
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Demi-Fontan procedures followed by LT completion Fontans. The
istribution of flow to the right and left lungs was essentially equal.
f the blood in the right PA and the left PA, 48% and 31%,
espectively, came from the IVC.
More recently, using computational fluid dynamics, Ed Bove
nd Mark de Leval not only found that the LT after the hemi-
ontan had considerably lower power losses than the EC Fontan,
ut they corroborated our earlier finding with IVC flow to the right
ung being 52% for the LT, just 19% for the EC, and only 15% for
he EC with a bevel to the left lung, as illustrated by Dr Hanley.
learly, the type of surgical reconstruction affects where the
enous blood goes, and Dr Hanley’s own group has been among
hose taking the lead in emphasizing the important influence of
epatic venous blood on the health of the pulmonary vasculature.
My first question is this. Recognizing the potential for late-
hase deterioration of the Fontan circulation and notwithstanding
he excellent short-term results that you have achieved, do you
ave any concern that the effort to minimize the use of bypass has
elegated your patients to a type of cavopulmonary connection that
ight have less than optimal properties with respect to energy
onservation or with respect to the long-term health and function
f the pulmonary vascular bed?
Dr Hanley. Thank you, Marshall, for your pertinent and
houghtful questions and analysis. Yes, we do have these concerns,
nd, of course, we are monitoring these patients in an ongoing
ashion. I think you can pick your study from those studies
vailable in the literature, in terms of computational fluid dynam-
cs, and certainly there are others that state very definitively that an
C provides the least amount of overall energy loss.
In terms of the distribution of flow to each lung, we position the
C so that it goes off to the left side. I see that as a very good
rrangement in terms of energy loss. It may bias the IVC flow to
he left side, but certainly not exclusively to the left. We have
agnetic resonance images that back this up. However, more
mportantly, from a practical standpoint, our mean oxygen satura-
ion is 95% at late follow-up up to 12 years, indicating that
ulmonary arteriovenous malformations are not developing, which
s what I think you are concerned about here.
Dr Jacobs. My second and only other question pertains to
otential consequences of cannulation, either for bypass or for
inimal circulatory support. In 2001 at this meeting, Dr Hanley’s
roup read a paper emphasizing the important adverse conse-
uence of hemidiaphragm paralysis in Fontan patients, with a
eported incidence of 2.7%. This complication was associated with
ignificant morbidity, early from effusions and late from protein-
osing enteropathy.
For this and other reasons, in our practice we completely avoid
aval cannulation for the Fontan operation and instead have used
single venous cannula in the atrial appendage, and, a very
ifferent strategy from Dr Hanley’s, a very brief period of hypo- r
The Journal of Thoracichermic circulatory arrest, to construct the cavopulmonary connec-
ion. Avoidance of redissection of the area around the cavae has
esulted in complete freedom from phrenic nerve injury, and in 93
onsecutive patients there have been no deaths and no Fontan
ailures. The only neurologic morbidity has been transient seizures
n 1 patient with previous cerebral disease, which is a low inci-
ence comparable to your series.
With the dissection and presumably tourniquet placement
round caval cannulation sites, has there continued to be an inci-
ence of postoperative diaphragm paralysis in your Fontan
atients?
Dr Hanley. The earlier study that you referred to evaluated
iaphragm palsy in patients late after Fontan, and it was looking at
he impact of the inefficient diaphragm in the context of the limited
ontan physiology. Many of those diaphragm palsies had occurred
efore the Fontan operation, and the study was also multicentered,
ncluding several different Fontan techniques. Thus only a small
umber of diaphragm palsies have occurred in our hands at the
ime of the EC Fontan operation. However, your point is very well
aken. A very precise surgical dissection is required here.
I think Ed Petrossian is in the audience here, but I do not
hink in the past 5 years we have had any diaphragm palsies in
he series.
Dr Pedro J. del Nido (Boston, Mass). This is an excellent
eries, and I would echo what Dr Jacobs has said, that in other
eries using other types of cavopulmonary connections, other
enters, including ours, have reported 10-year follow-up with
imilarly low mortality and supraventricular tachycardia rates.
My question relates to the issue of the oxygenator. You have
dentified this as a risk factor, but is that a fair comparison given
he fact that your study is not contemporaneous and that it was a
nivariate analysis?
How many of the patients who were on CPB also had aortic
rossclamping and, therefore, ischemic time, and was this a factor?
n other words, if you had taken into account these other variables,
ould this risk factor of an oxygenator simply fall out?
Dr Hanley. That is a very good question. This was not a
andomized prospective study of oxygenator versus no oxygenator.
here has been an evolution of the technique, and I do not think we
an tease the factor that you are referring to out of the data. Our
tandard policy right from the beginning was warm normothermic
eating bypass with no crossclamp. Even the typical full bypass
uns early in the series were performed with no aortic crossclamp
xcept for a very small number of patients.
In general, I agree with your mortality comment, but I have not
een numbers in the literature from series performed predomi-
antly using techniques other than the EC that show supraventric-
lar tachycardia rates, and certainly not sinus node dysfunction
ates, as low as we have seen.
and Cardiovascular Surgery ● Volume 132, Number 5 1063
